Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

5E10: a prostate-specific surface-reactive monoclonal antibody

O W Rokhlin1, G J Weiner, M B Cohen

  • 1Department of Pathology, University of Iowa, Iowa City 52242, USA.

Cancer Letters
|December 16, 1998
PubMed
Summary

Researchers developed a novel monoclonal antibody (mAb) that specifically targets prostate epithelial cells. This antibody, 5E10, shows high specificity for both benign and malignant prostate tissues, offering potential for targeted prostate cancer diagnostics and therapeutics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Active Precipitation of Radiation Belt Electrons Using Rocket Exhaust Driven Amplification (REDA) of Man-Made Whistlers.

Journal of geophysical research. Space physics·2022
Same author

Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma.

Blood cancer journal·2017
Same author

Induction of cytochrome P450-mediated detoxification of xanthotoxin in the black swallowtail.

Journal of chemical ecology·2013
Same author

Histamine azoprotein in the treatment of allergy.

The Journal of allergy·2010
Same author

The effect of beta-dimethylaminoethyl-benzhydryl-ether-hydrochloride on the histamine threshold of human skin.

The Journal of allergy·2010
Same author

Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis.

American journal of physiology. Gastrointestinal and liver physiology·2009

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • Prostate cancer diagnosis and treatment require specific biomarkers.
  • Monoclonal antibodies (mAbs) offer high specificity for targeted therapies.

Purpose of the Study:

  • To develop a monoclonal antibody that selectively binds to prostate epithelial cells.
  • To characterize the specificity and target antigen of the novel mAb for potential clinical applications.

Main Methods:

  • Immunization of mice with a mixture of prostate carcinoma cell lines.
  • Screening of antibodies using flow cytometry against a panel of prostate and non-prostate cell lines.
  • Characterization of antibody reactivity with histological samples and cell types.
  • Identification of the antigen as a 110 kDa transmembrane glycoprotein.

Related Experiment Videos

Main Results:

  • A specific monoclonal antibody, 5E10 (IgG1), was generated.
  • 5E10 mAb demonstrated selective reactivity with four of six prostate cancer cell lines.
  • No reactivity was observed with non-prostate cell lines, mononuclear cells, or stromal cells.
  • 5E10 mAb reacted with both benign and malignant prostate tissues but not with non-prostate normal tissues.
  • The 5E10 antigen is a 110 kDa transmembrane glycoprotein with an extracellular epitope.

Conclusions:

  • The 5E10 mAb is a highly specific reagent for prostate epithelial cells.
  • This antibody has potential as a diagnostic marker or therapeutic target in prostate cancer.
  • Further research is ongoing to elucidate the precise nature of the 5E10 antigen.